We find that in colon cancer cells harboring a KRASG13D mutant allele, knocking down KRAS alone or the RAFs in combination or the RAF effectors, MEK1 and MEK2, together is effective in delaying tumor growth in vivo. This evidence concerns the gene RAF1 and colonic neoplasm.